rs200334019
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001848.3(COL6A1):c.1741-6G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001848.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A1 | NM_001848.3 | c.1741-6G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000361866.8 | NP_001839.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A1 | ENST00000361866.8 | c.1741-6G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001848.3 | ENSP00000355180 | P1 | |||
COL6A1 | ENST00000466285.1 | n.252G>A | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151960Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249790Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135366
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461266Hom.: 0 Cov.: 33 AF XY: 0.0000385 AC XY: 28AN XY: 726942
GnomAD4 genome AF: 0.000158 AC: 24AN: 152078Hom.: 0 Cov.: 30 AF XY: 0.000121 AC XY: 9AN XY: 74346
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1Benign:1
Likely pathogenic, no assertion criteria provided | provider interpretation | Solve-RD Consortium | Jun 01, 2022 | Variant confirmed as disease-causing by referring clinical team - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | - - |
Ullrich congenital muscular dystrophy 1A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Feb 09, 2023 | The variant has been reported in three unrelated, turkish patients (in homozygosity) with collagen-VI-related dystrophies. The variant were absent in homozygosity in large population studies, but has fairly high frequency in heterozygosity (gnomAD). The aberrant splicing was verified by cDNA analysis and nanopore sequencing showing that the variant induced aberrant splicing leading to a frameshift and loss of function. The RNA analysis was in line with immunocytochemistry studies of patient-derived skin fibroblasts demonstrating impaired secretion of collagen VI into the extracellular matrix. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 15, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at